<DOC>
<DOCNO>EP-0613479</DOCNO> 
<TEXT>
<INVENTION-TITLE>
MARCFORTINE/PARAHERQUAMIDE DERIVATIVES USEFUL AS ANTIPARASITIC AGENTS.
</INVENTION-TITLE>
<CLASSIFICATIONS>A01N4390	A01N4390	A61K31495	A61K31495	A61K3566	A61K3574	A61P3300	A61P3310	C07D49100	C07D49122	C07F700	C07F710	C07F900	C07F96561	C12N114	C12N114	C12P1718	C12P1718	C12R180	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A01N	A01N	A61K	A61K	A61K	A61K	A61P	A61P	C07D	C07D	C07F	C07F	C07F	C07F	C12N	C12N	C12P	C12P	C12R	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A01N43	A01N43	A61K31	A61K31	A61K35	A61K35	A61P33	A61P33	C07D491	C07D491	C07F7	C07F7	C07F9	C07F9	C12N1	C12N1	C12P17	C12P17	C12R1	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
There are disclosed 18-thiomarcfortine derivatives of the natural products marcfortine A, B, and C, C-18 thioparaherquamide and derivatives thereof, novel N-1 marcfortines A, B, and C and derivatives thereof, novel N-1 paraherquamide and derivatives thereof useful in the treatment and prevention of helminth and arthropod infections of animals and plants. The synthetic derivatives are of Formula (I).
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
UPJOHN CO
</APPLICANT-NAME>
<APPLICANT-NAME>
THE UPJOHN COMPANY
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
LEE BYUNG HYUN
</INVENTOR-NAME>
<INVENTOR-NAME>
MARSHALL VINCENT P
</INVENTOR-NAME>
<INVENTOR-NAME>
NELSON STEPHEN J
</INVENTOR-NAME>
<INVENTOR-NAME>
TAYLOR RENATE N
</INVENTOR-NAME>
<INVENTOR-NAME>
WHALEY HOWARD A
</INVENTOR-NAME>
<INVENTOR-NAME>
LEE, BYUNG, HYUN
</INVENTOR-NAME>
<INVENTOR-NAME>
MARSHALL, VINCENT, P.
</INVENTOR-NAME>
<INVENTOR-NAME>
NELSON, STEPHEN, J.
</INVENTOR-NAME>
<INVENTOR-NAME>
TAYLOR, RENATE, N.
</INVENTOR-NAME>
<INVENTOR-NAME>
WHALEY, HOWARD, A.
</INVENTOR-NAME>
</INVENTORS>
<DESCRIPTION>
 MARCFORTINE/PARAHERQUAMIDE DERIVATIVES USEFUL AS ANTIPARASITIC AGENTSBACKGROUND OF THE INVENTIONThe marcfortines are known compounds and are disclosed by Polonsky et al. in Journal of the Chemical Society Chemical Communications 1980 601-602 (Marcfortine A) andTetrahedron Letters 1981 22 1977-1980 (Marcfortines B and C). The compounds are fungal metabolites of Penicillium roqueforti. The marcfortines are structurally related to the paraherquamides which are also known compounds. The paraherqu amides are disclosed byYamazaki et al. in Tetrahedron Letters 1981 22 135-136, and by Blanchflower et al., Journal of Antibiotics, 1991, 44, 492-497. U.S. Patents 4,866,060 and 4,923,867 disclose the use of the marcfortines A, B, and C, and certain derivatives thereof as useful for the treatment and prevention of parasitic diseases in animals.Paraherquamide has the following structure:Marcfortine A has the following structure:
 Marcfortine B has the following structure:Marcfortine C has the following structure:WO 91/09961 (published 11 My 1991) discloses various derivatives of marcfortine and paraherquamide, and N(12) oxides thereof, well as the production the production of VM 29919 (paraherquamide) and VM 55596 (the N(12)oxide of paraherquamide) inter alia firom Penicillium Sp. IMI 332995.US Patent 4,873,247 discloses derivatives of paraherquamide and a strain of Penicillium charlessi MF 5123 (ATCC 20841) for the production of paraherquamide. US Patent 4,978, 656 (as well as EP 390532-A, EP-301742-A) discloses various synthetic derivatives of paraherquamide as well as the production of paraherquamide from Penicillium charlessi MF 5123 (ATCC 20841).Paraherquamide is a compound produced under certain conditions by the fungal organism Penicllium paraherquei. WO 92/00300 (published 9 January 1992) discloses the 

 synthesis paraherquamide related compounds produced from Penicillium paraherquei, deposited at the C.A.B. International Mycological Institute, Ferry Lane, Kew, London, under deposit number CMI 68220.SUMMARY OF THE INVENTION This invention is concerned with the synthesis of C-18 thiomarcfortines A. B, and C and derivatives thereof, C-18 thioparaherquamide and derivatives thereof, novel N-l marcfortines A, B, and C and derivatives thereof, novel N-l paraherquamide and derivatives thereof, and the use of these compounds as antiparasitic agents. Thus it is an object of this invention to describe these thiomarcfortine, thioparaherquamide, marcfortine and paraherquamide derivatives. A further objective of this
</DESCRIPTION>
<CLAIMS>
CLAIMS
1. A compound of Formula I
wherein: n is 0 or 1;
R
Ma
 and R
14b
, being the same or different, are selected from hydrogen, hydroxy, C C
6
 alkyl, Cj-C
6
 alkoxy, C
r
C
6
 alkenyl, C
r
C
6
 alkenyl-C
r
C
6
 alkoxy, C
r
C
6
 alkynyl-C
r
C
6
 alkoxy, C
r
C
6
 alkynoyloxy, poly C
r
C
6
 alkoxy-C
r
C
6
 alkoxy, phenyl, phenyl- - alkyl, tri-C C
6
 alkylsilyloxy, diphenylphosphoryloxy and halogen, or R
14a
 and R
14b
 together form the epoxide or =CH
2
, with the provisio that when n is 1, then R
14a
 and R
14b
 are both hydrogen; m is 0 or 1; W is O or S; when W is S, R
j
 is hydrogen, -C, alkyl, cyclo C
3
-C
8
alkyl, benzyl, -C, alkanoyl 


 (optionally substituted with carboxy (-COOH), -C, alkanoyl, carbo C
j
- alkoxy (-C(0)OC
1
-C
7
alkyl), -NR
4
R
5
, aminocarbonyl (-C(0)NR
4
R
5
) } , 


 (-C(O)C
10
-C
24
alkyl, cyclo C
3
-C
8
alkanoyl (optionally substituted with carboxy, - alkanoyl, carboC
j
- alkoxy, -NR
4
R
5
, aminocarbonyl } , alkanoyloxymethylene (-CH
2
OC(0)-C
2
-C
7
alkyl), benzoyloxymethlene (-CH
2
OC(0)phenyl) (optionally substituted with 1 or 2 groups selected from halogen, C
r
C
4
 alkyl, haloCi- alkyl, nitro, cyano and - alkoxy}, 


 (-C(0)C
9
-C
23
alkenyl), benzenesulfonyl (-S0
2
CH
2
phenyl) (optionally substituted with 1 or 2 groups selected from halogen, C
r
C
4
 alkyl, haloC
1
-C
7
alkyl, nitro, cyano and - alkoxy), C
r
C
4
alkylaminocarbonyl (-C(0)N(C
1
-C
4
alkyl)
2
), C
r
C
4
alkylaminothiocarbonyl (-C(S)N (C
1
-C
4
alkyl)
2
), -C, alkoxycarbonyl, phenoxycarbonyl (optionally substituted with 1 or 2 groups selected from halogen, C
r
C
4
 alkyl, halo - alkyl, nitro, cyano and C
j
- alkoxy),
-C(0)NR'
4
R'
5
, 


 -SR
6
_ -S0
2
NR
4
R5, benzoyl substituted at the 3 or 4 position with 


 -CH
2
NR
4
R
5
, 2-tetrahydrofuran, or bicycloC
8
-C
12
alkanoyl; when W is O; R
x
 is selected from the group consisting of:
(a) -C alkanoyl substimted with carboxy (-COOH), -C
6
 alkanoyl, carboC
1
-C
7
alkoxy (-C(0)OC
1
-C
7
alkyl), -NR
4
R
5
, aminocarbonyl (-C(0)NR
4
R
5
);
(b) cyclo -Cgalkanoyl optionally substimted with carboxy, -C, alkanoyl, carboCj-Cjalkoxy, -NR
4
R
5
, aminocarbonyl;
(c) alkanoyloxymethylene (-CHzOQOiJ- .-Cjalkyl);
(d) benzoyloxymethlene (-CH
2
OC(0)phenyl) substimted with 1 or 2 groups selected from halogen, C
r
C
4
 alkyl, halo - alkyl, nitro, cyano and - alkoxy;
(e) phenoxycarbonyl substimted with 1 or 2 groups selected from halogen, Cj- alkyl, halo - alkyl, nitro, cyano and Cj- alkoxy;
(f) -C(0)NR'
4
R'
5
; (g) -P(=X)(R
2
)(R
3
);
(h) -SR* 


 (j) 


 (-C(0)C
9
- 
3
alkenyl); or (k) 2-tetrahydrofuran; R
4
 and R
5
, being the same or different, are selected from hydrogen, - alkyl, phenyl
(optionally substimted with 1 or 2 groups selected from halogen, C
r
C
4
 alkyl, haloC
j
- alkyl, nitro, cyano and - alkoxy} or when taken together with N, form a saturated or unsaturated heterocyclic amine ring;
R'
4
 and R'
5
, being the same or different, are selected firom - alkyl, cyclo(C
3
-Cg)alkyl, phenyl (optionally substimted with 1 or 2 groups selected from halogen,
C
r
C
4
 alkyl, halo - alkyl, nitro, cyano and -Cyalkoxy} or when taken together with N, form a samrated heterocyclic amine ring optionally containing 1 or 2 additional heteroatoms selected from N, O or S;
X is O or S; R
2
 and R
3
, being the same or different, are selected from -C, alkyl, phenyl (optionally substimted with 1 or 2 groups selected from halogen, C
r
C
4
 alkyl, halo -Cjalkyl, nitro, cyano and - alkoxy}, -C, alkoxy, thioC -C^alkoxy, phenoxy, thiophenoxy, -NR
7
R
8
 (where R
7
 and R
g
, being the same or different, are selected from H, C
j
-C, alkyl or taken together with N, form a saturated heterocyclic ring}, or taken together with P form a 4- to 7-membered heterocyclic ring;
R
6
 is -C, alkyl, halo -C^alkyl, carboCj- alkoxy, -NRgRjo where R, and R
10
, being 


 the same or different, are -C, alkyl or phenyl (optionally substimted with 1 or 2 groups selected from halo, lower alkyl, haloC
1
-C
7
alkyl, nitro, cyano, - alkoxy); R
24
 is hydrogen, halogen or -C, alkoxy; R
25
 is hydrogen or halogen; Rι
8a
 is hydrogen, - alkyl, -Cg alkoxyalkyl, C
2
-C
8
 alkenyl, G,-C
8
 alkynyl or benzyl; the broken line between carbons 24 and 25 represents a single or double bond; and pharmaceutically acceptable salts and hydrates thereof.
2. A compound according to Claim 1 where m is 0.
3. A compound according to claim 2 where R
24
 and R
25
 are hydrogen; R
18a
 is hydrogen,
Cj- alkyl, C
r
C
8
 alkoxymethyl, Cj-Cg alkenyl or benzyl; and the broken line represents a double bond between carbons 24 and 25.
A compound according to claim 1 where W is S and n is 0.
5. A compound according to claim 4 where m is 0; R^ and R
25
 are hydrogen; R
18a
 is hydrogen, C C- alkyl, -Cg alkoxymethyl, -Cg alkenyl or benzyl; and the broken line represents a double bond between carbons 24 and 25.
6. A compound according to claim 5 which is selected from 18-thiomarcfortine A;
1 -acetoxymethyl- 18-thiomarcfortine A; l-diethoxyphosphoryl-18-thiomarcfortine A;
1-dimet ylsulfamoyl-l 8-thiomarcfortine A; l-cyclopropylcarbonyl-18-thiomarcfortine A; l-(l-piperidinyl)thiocarbonyl-18-thiomarcfortine A; l-succinoyl-18-thiomarcfortine A; l-(2,4-dinitrobenzenesulfenyl)-18-thiomarcfortine A; l-(4-mo holinosulfenyl)-18-thiomarcfortine A;
24-propoxy-24,25-dihydro- 18-thiomarcfortine A; l-(p-toluenesulfonyl)- 18-thiomarcfortine A;
1 -acetyl- 18-thiomarcfortine A; l-methyl-18-thiomarcfortine A; l-benzyl-18-thiomarcfortine A; 


 l-dimethylcaιbamoyI-18-thiomarcfortine A; l-methoxycarbonyl-18-thiomarcfortine A; I8-thiomarcfortine B; 24,25-dihydro-18-thiomarcfoitine B; 24-methoxy-24,25-dihydro-18-thiomarcfortine B; l-(p-toluenesulfonyl)-18-thiomarcfortine B; l-acetyI-18-thiomarcfortine B; l-ethyI-18-thiomarcfortine B; l-benzyl-18-thiomarcfortine B; 18a-ethyl-18-thiomarcfortine B;
18a-benzyl-18-thiomarcfortine B; 18a-methoxyethoxymethyl-l 8-thiomarcfortine B ; 18a-allyI-18-thiomarcfortine B; 18a-propargyI-18-thiomarcforύne B; 18a-ethyI-24-methoxy-24,25-d--hydro-18-thiomarcfortine B;
18 ethyl-18-benzyI-18-thiomarcfortine B; 18a-ethyl-24-methoxy-18-thiomarcfortine B; l-(2,4-dinitrobenzene sulfonyl)-l 8a-ethyl-24-methoxy-24,25-dihydro- 18-thiomarcfortine B; 18a-ethyl-24,25 dihydro-18-thiomarcfortine B;
18-thiomarcfortine C; 24,25 dihydro-18-thiomarcfortine C; l-(p-bromobenzene sulfonyl)-18-thiomarcfortine C; l-propionyl-18-thiomarcfortine C; I-propyl-18-thiomarcfortine C; l-benzyl-18-thiomarcfortine C; 18a-propyl-18-thiomarcfortine C; 18a-benzyl-I8-thiomarcfortine C; 18a-methoxyethoxymethyl-l 8-thiomarcfortine C; I8a-alIyl-18-t iomarcfortine C;
18a-propargyl-l 8-propyl-18-benzyl-l 8-thiomarcfortine C; l-(4-caι jethoxy-l,3-t azolidimn-3-yl)caΛonyl-18-tWomarcfortine A; l-palmitoyI-18-thiomarcfortine A; or l-(4-morpholinocarbonyl)-18-thiomarcfortine A.
7. A compound according to claim 1 where W is S and n is 1. 


 8. A compound according to claim 7 where m is 0; R
u
 and R
25
 are hydrogen; R
18a
 is hydrogen, C
r
 j alkyl, C
r
C
8
 alkoxymethyl, C,-C
8
 alkenyl or benzyl; and the broken line represents a double bond between carbons 24 and 25.
9. A compound according to Claim 8 where R
14a
 and R
Mb
 are both hydrogen.
10. A compound according to Claim 8 where R
14a
 is methyl, Rι
4b
 is hydroxy.
11. A compound according to claim 8 which is selected from 18-thioparaherquamide
24,25-dihydro- 18-thioparaherquamide
14-O-methyl- 18-thioparaherquamide
14-O-ethyl- 18-thioparaherquamide
14-O-butyl- 18-thioparaherquamide 14-0-benzyl-18-thioparaherquamide
14-O-ally- 18 -thioparaherquamide
14-O-propargyl- 18-thioparaherquamide
14-O-methoxym ethyl- 18-thioparaherquamide
14-0-methoxy-ethoxy-18-thioparaherquamide 14-O-methoxy-ethyoxy-methyl- 18-thioparaherquamide
17-methyl-18-thioparaherquamide
17-methylene- 18-thioparaherquamide
1 -N-(p-toluenesulfonyl)- 18-thioparaherquamide
24-methoxy-24,25-dihydro- 18-thioparaherquamide
12. A compound according to Claim 1 wherein W is O and n is 0.
13. A compound according to claim 12 where m is 0; R
u
 and R
25
 are hydrogen; R
18a
 is hydrogen, -C, alkyl, C
r
C
8
 alkoxymethyl, - alkenyl or benzyl; and the broken line represents a double bond between carbons 24 and 25.
14. A compound according to claim 12 which is selected from l-(l-piperidinyl)thiocarbonyl-marcfortine C;
1 -( 1 -piperidinyl)thiocarbonyl-marcfortine A; l-(2,4-dichlorophenoxy)carbonyl- 18a-N-ethyl-24-methoxy-24,25-dihydro-marcfoιtine B; l-(2,4-dichlorophenoxycarbonyl)-18a-allyl-marcfortine B; 


 l-(2,4-dimtrobenzenesulfenyl)-marcfortine A;
I-(3-acetoxy)propionyl-18a-N-propargyl-marcfortine B; l-(4-caΛetiιoxy-l,3-t azolidine-3-yl)carbonyl-marcfortine A; l-(4-morpholinosuIfenyl)-marcfortine C; l-(4-oxobuty-7l)-18a-methyl-marcfortine C; l-(4-oxopentanoyl)-marcfortine A; l-(4-oxopentanoyl)-marcfortine C;
1-3,4-dichIorobenzoyloxy-marcfortine C;
1-acetoxymethyl marcfortine C; l-acetoxymethyl-I8a-benzyl-marcforrine B; l-benzoyloxymetliyl-marcfortine A;
1-cyclohexylcarbonyl-marcfortine A; l-cyclohexylcarbonyl-marcfortine C; l-cyclopropylcarbonyl-marcfortine A; l-cyclopropylcarbonyl-18a-ethyl-marcfortine B; l-cyclopropylcarbonyl-marcfortine C;
I-dϊethoxyphosphoryl-marcfortine A; l-diethoxythiophosphoryl-marcfortine A; l-diethoxythiophosphoryl-marcfortine C; l-dimemylammoacetyl-marcfortine C; l-dimethylaminoacetyl-marcfortine A; l-dimethylaminosulfenyl-18a-N-benzyI-marcfortine B; 1-diphenyIphosphinyI-l 8a-N-aIlyl-marcfortine B ; l-ethoxycaιbonylsuIfenyI-18a-methyl-marcfortine C; I-ethoxycaιbonylsulfenyl-18a-N-methoxyethoxymelhyl-marcfortine B; l-N-(2,4-dmitrotenzenesu-fenyl)-18a-N-ethyl-marcfortine B; l-N-(4-carbethoxy-l,3-tWazoUdιurι-3-yl)carbonyl-marcfoιtine C; l-N-(4-carbethoxy-l ,3-tWazoUdinin-3-yl)carbonyl-marcfortine A; l-N-(p-bromobenzenesulfenyl)-marcfortine C; 1-NJ^-dimethylsuccinamidoyl-marcfortine A; 1-N-N-dtaethyIsuccinamidoyI-marcfortine C; l-phenoxyca-tf-Kmyl-marcfortine C; l-phenylmethoxyphosphonyl-marcfortine A; 1-phenylmethoxyphosphonyl-marcfortine C; 1-succinoyI-marcfortine A; l-succinoyl-marcfortine C; 


 1-t-butyryloxymethyl-marcfortine A; or
1 -trichloromethylsulfenyl- 18a-ethyl -marcfortine B.
15. A compound according to Claim 1 selected from preferably 1-cyclopropylcarbonyl-marcfortine A
1 -phenoxycarbonyl -marcfortine A
1-palmitoyl-marcfortine A l-[[(4-nitrophenyl)oxy]carbonyl]
-marcfortine A l-(l-piperidinecarbonyl)-marcfortine A l-[[4-(ethoxycarbonyl)piperazin-l-yl]carbonyl]
-marcfortine A l-[[4-(benzyl)piperazin-l-yl]carbonyl]
-marcfortine A l-[[4-(l,3-benzodioxol-5-yl-methyl)piperazin-l-yl]carbonyl]
-marcfortine A l-[[4-(methyI)piperazin-l-yl]carbonyl]
-marcfortine A l-(l,3-dihydro-l,3-dioxo-2H-isoindol-2-yl)-marcfortine A l-[[4-(pyridin-2-yl)piperazin-l-yl]carbonyl]
-marcfortine A l-[[4-(phenyl)piperazin-l-yl]carbonyl]
-marcfortine A l-[[4-(chlorocarbonyl)piperazin-l-yl]carbonyl]
-marcfortine A l-[(4-(phenyl)piperidin-l-yl]carbonyl]
-marcfortine A l-[[4-(phenyl)(dimethyl)piperidin-l-yl]carbonyl]
-marcfortine A l-[[4-(5-chloropyridazin-3-yl)piperazin-l-yl]carbonyl]
-marcfortine A l-[[4-(4-chlorophenyl)piperazin- l-yl]carbonyl]
-marcfortine A l-([4-(trichloroethoxycarbonyl)piperazin-l-yl]carbonyl]
-marcfortine A l-[[4-(3-trifluoromethyl-thiadiazol-l-yl)piperazin-l-yl]carbonyl]
-marcforti-ne-A
1-acetoxymethyl-marcfortine A l-(2,4-dinitrobenzenesulfenyl)-marcfortine A
1 -(4-moφholinosulf enyl)-marcfortine A l-(trichloromethylsulfenyl)-marcfortine A l-(methoxycarbonylsulfenyl)-marcfortine A l-(benzenesulfenyl)-marcfortine A l-(2-tetrahydrofuranyl)-marcfortine A, l-(4-moφholinocarbonyl)-marcfortine A or l-(4-moφholinocarbonyl)-marcfortine A N-oxide.
16. A compound according to claim 1 selected from 1-diethoxyphosphoryl -paraherquamide
1 -cyclopropylcarbonyl-paraherquamide 


 1 -( 1 -pϊperidinyl)thiocarbonyl-paraherquamide
1-succinoyl-paraherquamide l-( carbet-hoxy-l,3-tWazolidi-n -3-yl)caιbonyl-paraherquamide
1-phenoxycarbonyl-paraherquamide l-pyrrolidinylcarbonyl-paraherquamide l-t-butyryloxymethyl-paraherquamide l-benzoyloxymethyl-paraherquamide l-acetoxymethyl-18a-paraherquamide
1-3 ,4-dichlorobenzoyloxy-paraherquamide l-(2,4-dinitrobenzenesulfenyl)-paraherquamide l-(4-moφholinosulfenyl)-paraherquamide l-trichloromethylsulfenyI-18a-ethyl-paraherquamide l-ethoxycarbonyIsulfenyl-18a-methyl-paraherquamide 1-paImitoyI-paraherquamide 1-piperidinylcarbonyl-paraherquamide l-(4-mθφholinecarbonyl)-paraherquamide
17. A method for the treatment or prevention of helminth or arthropod infections in domesticated animals which comprises treating such animals with an effective amount of a compound of claim 1.
18. A method for the treatment of insect or nematode pests of plants which comprises treating said plants or the soil in which they grow with an effective amount of a compound of claim 1.
19. A composition useful for the treatment and prevention of helminth or arthropod infections of domesticated animals which is comprised of an inert carrier and a compound of claim I.
20. A composition useful for the prevention and treatment of insect or nematode pests of plants which is comprised of an inert carrier and a compound of claim 1.
21. A biologically pure culture of Penicillium sp. NRRL 18887. 


 22. A process for producing a compound of the formula:
which comprises: the biotransformation of a compound of the formula:
using a microorganism in an aqueous nutrient medium containing an assimilable source of carbon and an assimilable source of nitrogen under aerobic conditions.
23. The process of Claim 22 wherein the microorganism is a species of Cunninghamella or a mutant thereof.
24. The process of Claim 22 wherein the strain is selected from the group consisting of NRRL 1368, NRRL 1393, NRRL 3655 or ATCC 8688a. 


25. A compound selected from the group consisting of
10 10'
,
-(l,4-dicarbonylρiρerazine)bis(6
,
,7',8',9',10',10
,
a-hexahydro-l',l
,
,4,4,12
,
-pentamethyl) -[2'S-[2'.alpha.,3'a.aIpha.,9'a.aIpha.,10(2'"R*,3
,
"aS*9"
,
aS*,10'"aR*),10'a.beta.]] -Spiro[4H,8H-[l,4]
dioxepino[2,3-g]indole-8,2
Λ
(3'H)-[lH,4H-3a,9a](iminomethano) cyclopenta[b]
quinoIizin]-9,i (10H)-dione; or
10,10"-(I,4-dioxo-2-butene)bis(6',7',8
,
,9M0',10'a-hexahydro-l',l',4,4,12'-pentamethyl)-[2' S-[2.alpha.,3'a.alpha.,9
A
a.alpha.,10(2
//,
R* 3''
,
aS*9'''aS*,10'
,
'aR*),10'a.beta.]] -Spiro[4H,8H-[l,4]
dioxepino[2,3-g]indole-8,2'(3'H)-[lH,4H-3a,9a]
 (iminomethano)cycIopenta[b] quinoIizin]
-9, 1 l'(10H)-dione. 

</CLAIMS>
</TEXT>
</DOC>
